D. Zavaglia

Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein

B. Eymin, J. Coll, M. Favrot, 2003, Gene Therapy.

VP22-mediated and light-activated delivery of an anti-c-raf1 antisense oligonucleotide improves its activity after intratumoral injection in nude mice.

J. Coll, M. Favrot, P. O’Hare, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Poor intercellular transport and absence of enhanced antiproliferative activity after non‐viral gene transfer of VP22‐P53 or P53‐VP22 fusions into p53 null cell lines in vitro or in vivo

P. Hainaut, O. Pluquet, J. Coll, 2005, The journal of gene medicine.